FDA approves kids’ COVID-19 vaccine in U.S., Canada likely close behind
OTTAWA — The U.S. Food and Drug Administration has approved Pfizer-BioNTech’s COVID-19 vaccine for children aged five to 11, and Canada could be close behind.
The FDA confirmed the vaccine was more than 90 per cent effective in preventing COVID-19 in children and found no serious side-effects.
The FDA advisory committee recommended in favour of approving the vaccine after hours of testimony from experts.
Dr. Supriya Sharma, chief medical adviser at Health Canada, said Canadian officials attended that meeting and are watching the process in the U.S. carefully as Canada makes its own decision about the pediatric vaccine.